Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review.

Anders ForssPaulina FlisAdonis SotoodehMarjo KapraaliStaffan Rosenborg

Published in: Scandinavian journal of gastroenterology (2024)

Our findings suggest that vedolizumab, although rarely, could cause AIN in patients with IBD. Awareness of laboratory findings and symptoms consistent with AIN, along with monitoring of the kidney function, could be warranted in patients with IBD treated with vedolizumab.

Keyphrases

patients with inflammatory bowel disease
ulcerative colitis
newly diagnosed
intensive care unit
sleep quality
acute respiratory distress syndrome